Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al.

@article{Baal2013PharmacoeconomicGS,
  title={Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al.},
  author={Pieter H. M. van Baal and David Meltzer and Werner B. F. Brouwer},
  journal={PharmacoEconomics},
  year={2013},
  volume={31},
  pages={369-373}
}
Recently, Grima and colleagues [1] made a case for excluding unrelated medical costs in life-years gained from economic evaluations of life-prolonging interventions. They provide an insightful overview of several economic evaluations in patients with chronic kidney disease (CKD) on dialysis and convincingly show that inclusion or exclusion of dialysis costs has an enormous impact on the cost effectiveness of any intervention in this patient group (and that there is considerable practice… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Costing in economic evaluations

  • W Brouwer, F Rutten, M. Koopmanschap
  • Rapport Richtlijnen voor far - maco - economisch…
  • 2001
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…